Physician Resources
Recently Added |view more
Thoracic Malignancies: A Review of the Latest Evidence
Great therapeutic strides have been made for non-small cell lung cancer (NSCLC). In this CME, renowned specialists from Fox Chase Cancer Center, Temple Lung Center, Johns Hopkins Medicine, Yale Medicine, MedStar Georgetown University Hospital, ...
Complex Patient Case Review for Oncologic and Benign Urology
The Fox Chase–Temple Urologic Institute delivers expert care for both complex oncologic and benign urologic conditions. Backed by a team of renowned urologic specialists, we are recognized regionally and internationally for offering innovative, ...
Joseph Van Galen, MD, MS, Chief Fellow in the Hematology/Oncology Fellowship Program at Fox Chase Cancer Center
Married People May Have Better Colorectal Cancer Outcomes, Fox Chase Cancer Center Study Shows
Namrata Vijayvergia, MD, Assistant Chief of Gastrointestinal Medical Oncology at Fox Chase Cancer Center
Christopher Cann, MD, Director of the Young Adult Cancer Program and Assistant Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center
Parastomal hernia is a common complication among patients who undergo bladder removal and ileal conduit urinary diversion. Now, a new study “Very Low Rate of Parastomal Hernia Using Partially Absorbable Macroporous Mesh for Prophylactic ...
Local Excision Possible for More Rectal Cancer Patients, Fox Chase Cancer Center Study Finds
Results from a study presented by Fox Chase Cancer Center researchers at the Society of Surgical Oncology 2025 Annual Meeting suggest that chemotherapy followed by local excision is a promising treatment option for patients with node-negative ...
Removing and testing at least 18 lymph nodes during surgery was associated with more accurate staging and better survival rates for colon cancer patients, according to research presented today at the Society of Surgical Oncology 2025 Annual ...
INSITE Trial Looking to Identify Which Patients Can Forgo Cystectomy
Alexander Kutikov, MD, FACS, and Matthew R. Zibelman, MD, are conducting a new trial called INSITE to attempt to answer that question.